Copyright
©2009 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Sep 21, 2009; 15(35): 4415-4422
Published online Sep 21, 2009. doi: 10.3748/wjg.15.4415
Published online Sep 21, 2009. doi: 10.3748/wjg.15.4415
Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States
Muhammad Wasif Saif, Gastrointestinal Cancers Program, Yale Medical Oncology, New Haven, CT 06519, United States
Nianwen Shi, Thomson Reuters, Cambridge, MA 02140, United States
Susan Zelt, Medical Data Management and Analytics, Roche, Nutley, NJ 07110, United States
Author contributions: Saif MW, Shi N, and Zelt S contributed equally to this work, designed the research, performed the research, analyzed the data, and wrote the paper.
Supported by Roche
Correspondence to: Muhammad Wasif Saif, MD, Gastrointestinal Cancers Program, Yale Medical Oncology, 800 Howard Avenue, New Haven, CT 06519, United States. wasif.saif@yale.edu
Telephone: +1-203-737-1569 Fax: +1-203-737-2617
Received: July 27, 2009
Revised: August 21, 2009
Accepted: August 28, 2009
Published online: September 21, 2009
Revised: August 21, 2009
Accepted: August 28, 2009
Published online: September 21, 2009
Core Tip